Argenx Se ARGX
NASDAQ ARGX
$818.95 -27.32 (-3.23%)
As of: Oct 16, 2026 · 3:59 PM EDT

Argenx Se (ARGX) Equity Income (2022 - 2024)

Updated

Argenx Se (ARGX) recorded Equity Income of -$1.52 million in Q2 2024, compared with -$1.62 million a year earlier.

Analysis

Argenx Se (ARGX) Equity Income (2022 - 2024) Analysis & Trends

On a TTM basis, Argenx Se's Equity Income came in at -$5.84 million as of Jun 30, 2024; for FY2023, it came in at -$4.41 million.

  • Across earlier years, Equity Income came in at -$677,000 in FY2022.
  • Quarterly Equity Income has ranged from -$1.79 million in Q1 2024 to -$261,000 in Q1 2023 over the past five years.
  • Per Business Quant, the preceding three quarters came in at -$1.79 million (Q1 2024), -$1.79 million (Q4 2023) and -$743,000 (Q3 2023).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn -
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -2.00 Mn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn -10.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Argenx Se 50.23 Bn 34.19 Bn 1.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 -1.52 Mn
Mar 31, 2024 -1.79 Mn
Dec 31, 2023 -1.79 Mn
Sep 30, 2023 -743,000.00
Jun 30, 2023 -1.62 Mn
Mar 31, 2023 -261,000.00
Dec 31, 2022 -677,000.00
API Access

Argenx Se Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=ARGX&period=max&api_key=YOUR_API_KEY